MAZIN I. FOTEH, MD, F.A.C.S
4716 Alliance Blvd., Suite 200
Plano, Texas 75093
FELLOWSHIP
Endovascular Fellow
The University of Texas Southwestern Medical School
Dallas, TX
July 2011 – June 2012
Clinical Vascular Fellow
The University of Texas Southwestern Medical School
Dallas, TX
July 2010 – June 2011
RESIDENCY
Clinical Instructor, General Surgery
The University of Texas Southwestern Medical School
Dallas, TX
July 2006 – June 2010
INTERNSHIP
General Surgery Intern
The University of Texas Southwestern Medical School
Dallas, TX
July 2005 – June 2006
MEDICAL SCHOOL
The University of Texas Medical School at Houston
Houston, TX, MD, June 2005
UNDERGRADUATE
Texas A&M University B.A., Biology, May 2001
BOARD CERTIFICATION
General Surgery: American Board of Surgery
Certificate 56020
Expiration July 2021
Vascular Surgery: American Board of Surgery
Certificate 102402
Expiration July 2023
LICENSURE
Texas Medical Board
License Number N2501
June 2009 – Present
OTHER CERTIFICATION
Advanced Trauma Life Support (ATLS)
July 2005 – Present
Advanced Cardiac Life Support (ACLS)
July 2005 – Present
ACADEMIC APPOINTMENTS:
The University of Texas Dell Medical School at Austin Assistant Professor of Surgery and Perioperative Care (August 2016 – Present)
The University of Texas Southwestern Medical School Clinical Instructor Vascular Surgery
(July 2010 – June 2012)
PROFESSIONAL EXPERIENCE:
The University of Texas Dell Medical School at Austin Assistant Professor of Surgery and Perioperative Care (August 2016 – Present)
Cardiothoracic and Vascular Surgeons, Austin, TX (July 2012 – Present)
Heart Hospital of Austin, Austin, TX (July 2012 – Present)
Seton Medical Center Austin and Seton Family of Hospitals, Austin, TX (July 2012 – Present)
St. David’s Medical Center Austin, Austin, TX (July 2012 – Present)
St. David’s Family of Hospitals, Austin, TX (July 2012 – Present)
St. Paul University Hospital, Dallas, TX (July 2005 – June 2012)
Zale – Lipshy University Hospital, Dallas, TX (July 2005 – June 2012)
Parkland Memorial Hospital, Dallas, TX (July 2005 – June 2012)
Children’s Medical Center Dallas, Dallas, TX (July 2005 – June 2012)
North Texas Veterans Affairs Health System Dallas, TX (July 2005 – June 2012)
HONORS AND AWARDS:
• Super Doctors in Vascular Surgery, Texas Monthly Magazine, December 2016-2021
• Best in Vascular Surgery, Austin Monthly Magazine, January 2020-2021
• Texas Rising Star in Vascular Surgery, Texas Monthly Magazine, June 2015
• Texas Rising Star in Vascular Surgery, Texas Monthly Magazine, June 2014
• Texas Rising Star in Vascular Surgery, Texas Monthly Magazine, June 2013
• Guest Speaker, International Experts Forum, LINC Conference, Germany, January 2013
• Fellow Academic Teaching Award, UTSW, Dallas, TX, June 2012
• Resident Academic Teaching Award, UTSW, Dallas, TX, June 2010
• Resident Academic Excellence Award, Dallas, TX, June 2005, 2006, 2007
• Anatomy Teaching Instructor, Houston, TX, May 2003
• Magna Cum Laude Graduate, Texas A&M University, College Station, TX, May 2001
• College of Science, Faculty Achievement Award, Texas A&M University, College Station, TX, May 2001
• College of Science, Outstanding Biology Graduate, Texas A&M University, TX, May 2001
• College of Science, Deans List for Academic Achievement, Texas A&M University, TX, August 1997 – May 2001
• College of Science, Distinguished Students List, Texas A&M University, TX, May 2000
• National Society of Collegiate Scholars, Texas A&M University, College Station, TX, May 2000
• Tau Kappa Junior Honor Society, Texas A&M University, College Station, TX, May 1999
• Lambda Sigma Sophomore Honor Society, Texas A&M University, College Station, TX, May 1998
• Beta Beta Beta Biological Honor Society, Texas A&M University, College Station, TX, May 1998
• Golden Key National Honor Society, Texas A&M University, College Station, TX, May 1999
SOCIETAL ASSOCIATIONS:
• American Medical Association, June 2005 – Present
• American College of Surgeons, June 2005 – Present
• Parkland Surgical Society, June 2010 – Present
• Society of Vascular Surgeons, June 2010 – Present
• Travis County Medical Society, June 2010 – Present
• Southern Association of Vascular Surgeons, June 2015 – Present
• American Venous Forum, June 2015 – Present
• Outpatient Endovascular and Interventional Society, June 2015 – Present
MILESTONES:
• First Percutaneous TEVAR in Austin, TX. July 2012
• First Percutaneous TEVAR for Rupture Thoracic Aorta in Austin, TX. August 2012
• First Percutaneous Trans Tibial PAD intervention in Austin, TX. August 2012
• First Percutaneous Ruptured AAA EVAR in Austin, TX. November 2012
• First Flow Reversal Trans Carotid Stent in Texas. September 2013
• First Trans-endograft Coil Embolization of Type II Endoleak in Austin, TX. November 2014
• First Percutaneous Fenestrated EVAR in Austin, TX. February 2015
• First PEVAR under Local Anesthesia in Austin, TX. May 2015
• First Implant of the Medtronic EVO Endograft in Austin, TX. July 2015
• First Endovascular Repair of a TAAA with “Octopus” technique in Austin, TX. July 2015
• First Endovascular Repair of a TAAA with a Four Vessel Chimney technique in Austin, TX. March 2016
• First Endovascular Repair of Common Iliac Aneurysm with the Gore Iliac Branch Device in Texas, Austin, TX. March 2016
• First Transcaval Coil Embolization of Type II Endoleak after EVAR in Austin, TX. May 2017
• First GORE TBE Branched Graft Repair of Descending Thoracic Aneurysm in Austin, September 2017
First Four Vessel PMEG of TAAA in Austin, September 2017
• First Deployment of Terumo CROSS SEAL closure device in the United States, August 2018
- First Endovascular Repair of a Thoracoabdominal Aneurysm with the GORE TAMBE
Endograft in Austin, Tx. August 2020
- First Endovascular Repair of an AAA with Terumo TREO Endograft in the US. October
2020
- First Physician Modified Endograft Repair of TAAA in Austin November 2020.
BIBLIOGRAPHY:
BOOK CHAPTERS
1. Foteh, MI, Valentine, RJ. “Chronic Mesenteric Ischemia.” The SCORE Portal, Surgical Council on Resident Education Inc., July 2010.
2. Foteh, MI, Valentine, RJ. “Acute Mesenteric Ischemia.” The SCORE Portal, Surgical Council on Resident Education Inc., July 2010.
ABSTRACTS
1. Gregory A. Stanley MD1, Frank R. Arko III MD1, Mazin I. Foteh MD1, Michael E. Jessen MD2, and J. Michael DiMaio MD2. Hybrid Endovascular Treatment of an Anomalous Right Subclavian Artery Dissection in a Patient with Marfan Syndrome. Presented at Division of Vascular and Endovascular Surgery, Department of Cardiovascular and Thoracic Surgery, The University of Texas Southwestern Medical Center, Dallas, TX, January 2011.
2. Martyn Knowles MD, Mazin I. Foteh MD, Frank Arko MD. Fenestrated Repair of a Type 3 Endoleak Following Repair of a Thoracic Endovascular Aortic Aneurysm Repair. Presented at the Division of Vascular and Endovascular Surgery, The University of Texas Southwestern Medical Center, Dallas, TX, February 2011.
3. Martyn Knowles, MD, Gregory A. Stanley, MD, Mazin I. Foteh, MD, Sumona S. Smith, MD, G.Patrick Clagett, MD: Intraoperative Coil Embolization of Popliteal Artery Aneurysms: A Novel Approach. Presented at the Division of Vascular and Endovascular Surgery, The University of Texas Southwestern Medical Center, Dallas, TX, February 2011
JOURNALS (PEER REVIEWED)
1. Stanley GA, Arko FR 3rd, Foteh MI, Jessen ME, DiMaio JM. Hybrid endovascular treatment of an anomalous right subclavian artery dissection in a patient with Marfan syndrome. Ann Thorac Surg. 2012 Aug;94(2):639-41. Epub 2012 May 10.
2. Banerjee S, Pershwitz G, Sarode K, Mohammad A, Abu-Fadel MS, Baig MS, Tsai S, Little BB, Gigliotti OS, Soto-Cora E, Foteh MI, Rodriguez G, Klein A, Addo T, Luna M, Shammas NW, Prasad A, Brilakis ES. Stent and Non-Stent Based Outcomes of Infrainguinal Peripheral Artery Interventions From the Multicenter XLPAD Registry.J. Invasive Cardiol. 2015 Jan;27(1):14-8.
3. Kashyap VS, King AH, Foteh MI, Janko M, Jim J, Motaganahalli RL, Apple JM, Bose S, Kumins NH. A multi-institutional analysis of transcarotid artery revascularization compared to carotid endarterectomy.J Vasc Surg. 2019 Jul;70(1):123-129. doi: 10.1016/j.jvs.2018.09.060. Epub 2019 Jan 6.
4. Banerjee S, Jeon-Slaughter H, Armstrong EJ, Bajzer C, Abu-Fadel M, Khalili H, Prasad A, Bou Dargham B, Kamath P, Addo T, Luna M, Gigliotti O, Foteh M, Cawich I, Kinlay S, Ali M, Ramanan B, Niazi K, Tsai S, Shammas NW, Brilakis ES. Clinical Outcomes and Cost Comparisons of Stent and Non-Stent Interventions in Infrainguinal Peripheral Artery Disease: Insights From the Excellence in Peripheral Artery Disease (XLPAD) Registry. J Invasive Cardiol. 2019 Jan;31(1):1-9.
5. King AH, Kumins NH, Foteh MI, Jim J, Apple JM, Kashyap VS. The learning curve of transcarotid artery revascularization. J Vasc Surg. 2019 Aug;70(2):516-521. doi: 10.1016/j.jvs.2018.10.115. Epub 2019 Feb PMID:30718112
6. Kashyap VS, King AH, Foteh MI, Janko M, Jim J, Motaganahalli RL, Apple JM, Bose S, J Vasc Surg. 2019 Jul;70(1):123-129. doi: 10.1016/j.jvs.2018.09.060. Epub 2019 Jan 6.
7. Kumins NH, King AH, Jim J, Motaganahalli RL, Apple JM, Foteh MI, Cho JS, Kashyap. Duration of blood flow reversal during transcarotid artery revascularization does not affect outcome.VS.J Vasc Surg. 2019 Dec 31.
8. Wang SK, King AH, Kashyap VS, Foteh MI, Ambani RN, Apple JM, Fajardo AC,
Motaganahalli RL. Treatment of Carotid Restenosis Using Transcarotid Revascularization. Vasc Endovascular Surg. 2020 Jul;54(5):436-440. doi: 10.1177/1538574420923815. Epub 2020 May 12.
9. Kashyap VS, Schneider PA, Foteh M, Motaganahalli R, Shah R, Eckstein HH, Henao S,
LaMuraglia G, Stoner MC, Melton J, Massop D, Hanover T, Titus J, Moore WS,
Rodríguez-Carvajal R, Malas MB, Arko FR 3rd, Pierce D, Anain P, Oskin T; ROADSTER 2
Early Outcomes in the ROADSTER 2 Study of Transcarotid Artery Revascularization in
Patients With Significant Carotid Artery Disease.
Stroke. 2020 Sep;51(9):2620-2629. doi: 10.1161/STROKEAHA.120.030550. Epub 2020
Aug 19.
10. Kumins NH, King AH, Jim J, Motaganahalli RL, Apple JM, Foteh MI, Cho JS, Kashyap V;
Duration of blood flow reversal during transcarotid artery revascularization does not
affect outcome. J Vasc Surg. 2020 Aug;72(2):584-588. doi: 10.1016/j.jvs.2019.10.092.
EPub 2019 Dec 31.
11. Giannopoulos S, Speziale F, Vadalà G, Soukas P, Kuhn BA, Stoltz CL, Foteh MI, Mena-
Hurtado C, Armstrong EJ. Intravascular Lithotripsy for Treatment of Calcified Lesions
During Carotid Artery Stenting. J Endovasc Ther. 2020 Sep 1.
JOURNALS (NONE – PEER REVIEWED)
1. Foteh MI, Knowles MK, Valentine RJ. Endovascular Repair of Complex Thoracic Aortic Pathology, The New Gold Standard. Best Surgical Thinking. J. American College of Surgeons. 2012, Feb.
2. Foteh MI, Valentine RJ. Renal Artery Denervation for the Treatment of Refractory Hypertension. Best Surgical Thinking. J. American College of Surgeons. 2012, June.
3. Foteh MI. Endoanchors Advance Treatment of Aortic Aneurysms. Endovascular Today, 2016, June.
MEDIA (INTERVIEW)
1. Foteh MI. Flow Reversal in conjunction with Carotid Stenting: Use of the MICHI flow reversal system. KVUE News. Austin, TX. 2013, Oct.
2. Foteh MI. Flow Reversal in conjunction with Carotid Stenting: Use of the MICHI flow reversal system. Sirius Satellite Radio. Doctor Radio. New York, NY. 2013, Nov.
3. Foteh MI. Fenestrated Endograft Treatment of Thoracoabdominal Aneurysm Repair. KVUE News. Austin, TX. 2015, May.
4. Foteh, MI. Repair of a Complex AAA with Medtronic Endoanchor Placement. KXAN News. Austin, TX. 2015
5. Foteh MI. Fixed wing air ambulance extending healthcare across the state . KVUE News. Austin, TX. 2016, March.
TEACHING RECORD:
LECTURES AND PRESENTATIONS
1. The University of Texas Southwestern, Department of Surgery, Grand Rounds. Secondary Infections of Aortic Endografts. Dallas, Texas. January, 2010.
2. The University of Texas Southwestern, Department of Surgery, Grand Rounds. Visceral Artery Aneurysms, Texas. January, 2011.
3. Society of Vascular Surgeons Annual Meeting. The Pathogenesis of Primary Aortoenteric Fistula After EVAR. Chicago, IL. June, 2012.
4. Austin Physician Assistants Association. Endovascular Advancement in Vascular Surgery. Austin, TX. November, 2012.
5. LINC Symposium. Carotid Stenting in a Modern Private Practice. Leipzig, Germany. January, 2013.
6. LINC Symposium. Use of the MICHI Flow Reversal System for Carotid Stenting in the patient with Complex Aortic Arch Anatomy. Leipzig, Germany. January, 2013.
7. Mended Hearts. Heart Hospital of Austin. Advancements in Endovascular Surgery. Austin, TX. April, 2013.
8. Austin Trauma and Critical Care Conference. Endovascular Repair of Peripheral Arterial Injuries. Austin, TX. May, 2013
9. Calcium Summit, Cardiovascular Systems. Advancements in Peripheral Arterial Crossing Techniques. Las Vegas, NV. March, 2014.
10. Terumo. Advancements in Endovascular Surgery, A Surgeons perspective. Phoenix, AZ. September, 2014.
11. Calcium Summit, Cardiovascular Systems. Advancements in the Treatment of Peripheral Arterial Crossing Techniques. San Antonio, TX. January, 2015
12. Cardiovascular Systems. Pedal Access in the Treatment of Advanced Peripheral Artery Disease. Scottsdale AZ. March, 2015.
13. Aortic Symposium. Advancements in the Percutaneous Treatment of Abdominal and Thoracic Aortic Aneurysm Repair. Heart Hospital of Austin. Austin, TX. May, 2015.
14. Advanced Treatment of SFA Disease. Terumo. Palm Springs, CA. June, 2015.
15. Society of Vascular Surgery Annual Meeting. Use of MICHI Flow Reversal System in Carotid Stenting. Chicago, IL. June 18 – 21, 2015.
16. Citizens Healthcare Cardiology Grand Rounds. Advanced Treatment of Complex Aortic Pathology. Victoria, TX. August 4, 2015.
17. Aortic Symposium. Advancements in the Percutaneous Treatment of Abdominal and Thoracic Aortic Aneurysm Repair. Lubbock, TX. September, 2015
18. SAWC Fall Meeting. Peripheral Arterial Disease, The Diagnosis and Management. Las Vegas, NV. September 26-28, 2015.
19. VIVA, EndoAnchors Enhance Treatment Of Aortic Aneurysms: Experience In A Community Hospital, Las Vegas, NV. November 4, 2015.
20. Texas Vascular and Endovascular Society Annual Meeting, Superlative Results with Transcarotid Artery Revascularizaion. San Antonio, TX. Nov 6, 2015.
21. Veith Symposium. Complex AAA Repair (FEVAR, CHEVAR) in a Community Practice, The Good, The Bad, The Ugly. New York, NY. November 16 – 21, 2015.
22. Medtronic. Endonachors in the Treatment of Hostile Aortic Neck Anatomy. Scottsdale, AZ. December, 2015.
23. Medtronic. Endonachors in the Treatment of Hostile Aortic Neck Anatomy. Dallas, Texas. February, 2016.
24. Dell Medical School, The University of Texas. Cardiovascular Conference. Physician-assembled Endografts for the treatment of TAAA. Austin, TX. March, 2016.
25. Medtronic. Advancements in the Treatment of Complex Aortic Pathology. Houston, TX. March, 2016.
26. Medtronic. Endoanchors in the Treatment of Hostile Neck Anatomy. Oklahoma City, OK. April, 2016
27. Medtronic. Endonachors in the Treatment of Hostile Aortic Neck Anatomy. Denver, CO. April, 2016.
28. Universita Tor Vergata, Advancements in the Treatment of Complex Aortic Pathology. Milan, Italy, July 2016.
29. Universita Tor Padova, Advancements in the Treatment of Complex Aortic Pathology. Rome, Italy, July 2016.
30. Medtronic. Endonachors in the Treatment of Hostile Aortic Neck Anatomy. St. Louis, Missouri, August, 2016.
31. Western Vascular Society Annual Meeting, Stroke Rates with Transcarotid Artery Revascularization with Hgh-Rate Flow Reversal Embolic Protection are comparable with Standard Risk Carotid Endarterectomy. Colorado Springs, CO, September 2016.
32. Veith Annual Symposium. The Treatment of Complex Aortic Anatomy in a Community Vascular Practice. New York, NY, November, 2016.
33. Knapp Medical Conference. Wound Management in the setting of Early Revascularization for patients with CLI. South Padre Island, TX,. April 2016.
34. Knapp Medical Conference. Endovascular Management of Complex Thoracoabdominal Aneurysms.. South Padre Island, TX,. April 2016.
35. University of Texas San Antonio. Endovascular Management of Complex Thoracoabdominal Aneurysms. San Antonio TX,. September 2017.
36. Medtronic’s Meeting of the Minds. The use of Endoanchors for the Treatment of Hostile Neck in AAA repair. Austin, TX. May 2017.
37. UC San Diego. Vascular Conference. The Novel Use of Lutonix DCB for AV Access Maintenance. San Diego, CA. October, 2017.
38. UCLA Harbor View. Vascular Conference. The Novel Use of Lutonix DCB for AV Access Maintenance. Los Angeles, CA. October, 2017.
39. SAWC Fall Meeting. Peripheral Arterial Disease, The Diagnosis and Management. Las Vegas, NV. October, 2015.
40. Medtronic’s Meeting of the Minds. The use of Endoanchors for the Treatment of Hostile Neck in AAA repair. Austin, TX. October, 2017.
41. Terumo. Advancements in Endovascular PAD Surgery, A Surgeons perspective. Phoenix, AZ. January, 2017.
42. LINC 2018. Transcarotid Stenting with Flow Reverse Flow Neuroproctection is a safe and effective alternative to CEA for High-Risk Patients. Leipzig, Germany. January 31st, 2018
43. Charring Cross Symposium.. Transcarotid Stenting with Flow Reverse Flow Neuroproctection is a safe and effective alternative to CEA for High-Risk Patients. London, England April 24th, 2018.
44. Veith Annual Symposium. The Treatment of complex TYPE II Endoleaks after EVAR, Transcaval Approaches. New York, NY, November, 2019.
45. Veith Annual Symposium. Application of Mechanical Aspiration in with Penumbras Indigo in the Setting of Scute Lower Ext Ischemia. New York, NY, November 2019.
46. Western Vascular Society Meeting. Early Experience with the TREO stent graft for AAA. Webinar, October 2020.
47. Veith Annual Symposium. Treatment of Type 1A Endoleaks with Penumbra Ruby Coils. Orlando, FL, November 2021.
48. VESS Meeting. Treating Complex Aortic Pathologies with Terumo Relay Graft. Aspen, CO, January 2021.
49. Clinical Society of Vascular Surgeons. Treat of Complex Thoracic Aortic Pathology.
Las Vegas, NV, March 2022.
TRAINING COURSES:
1. Angioscore. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. February, 2013.
2. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. March, 2013.
3. Volcano. (OR, CATH, Teleconf) IVUS in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. April, 2013.
4. Endologix. (OR, CATH, Teleconf) Percutaneous EVAR. Training Course, Austin, TX. May, 2013.
5. Terumo. (OR, CATH, Teleconf) Percutaneous Large Bore Access and EVAR. Training Course, Austin, TX. June, 2013.
6. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. July, 2013.
7. Endologix. (OR, CATH, Teleconf) Percutaneous EVAR. Training Course, Austin, TX. August, 2013.
8. Cook Medical. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease and Drug Eluting Stent Technology. Training Course, Austin, TX. September, 2013.
9. Angioscore. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. October, 2013.
10. Atrium. (OR, CATH, Teleconf) Complex Aortoiliac Iliac Recanalization with Balloon Expandable Stents. Austin, TX. November, 2013.
11. Aptus Endosystems. (OR, CATH, Teleconf) The use of Endoanchors for the Treatment of Complex Neck Anatomy for PEVAR. Austin, TX. January, 2014.
12. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. February, 2014.
13. Volcano. (OR, CATH, Teleconf) IVUS in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. March, 2014.
14. Endologix. (OR, CATH, Teleconf) Percutaneous EVAR. Training Course, Austin, TX. April, 2014.
15. Angioscore. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. May, 2014.
16. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. June, 2014.
17. Calcium Summit, Cardiovascular Systems. Pedal Access Techniques, Cadaver Lab. San Francisco, CA. July, 2014.
18. Terumo. (OR, CATH, Teleconf) Percutaneous Large Bore Access and EVAR. Training Course, Austin, TX. August, 2014.
19. Volcano. (OR, CATH, Teleconf) IVUS in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. September, 201
20. Cook Medical. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease and Drug Eluting Stent Technology. Training Course, Austin, TX. October, 2014.
21. Aortic Symposium. Advancements in the Percutaneous Treatment of Abdominal and Thoracic Aortic Aneurysm Repair. Heart Hospital of Austin. Austin, TX. November, 2014.
22. Calcium Summit, Cardiovascular Systems. Pedal Access Techniques, Cadaver Lab. San Francisco, CA. November 2014.
23. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. January, 2014.
24. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. February, 2015.
25. Aortic Symposium. Advancements in the Percutaneous Treatment of Abdominal and Thoracic Aortic Aneurysm Repair. Heart Hospital of Austin. Austin, TX. February, 2015.
26. Atrium. (OR, CATH, Teleconf) Complex Aortoiliac Iliac Recanalization with Balloon Expandable Stents. Austin, TX. March, 2015.
27. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. April, 2015.
28. Gore Medical. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease with use of Viabahn Stents. Training Course, Austin, TX. May, 2015.
29. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. May, 2015.
30. Gore Medical. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. May, 2015
31. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. May, 2015.
32. Aortic Symposium. Advancements in the Percutaneous Treatment of Abdominal and Thoracic Aortic Aneurysm Repair. Heart Hospital of Austin. Austin, TX. May, 2015.
33. Medtronic. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH, Teleconf). Training Course, Austin, TX. May, 2015.
34. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. June, 2015.
35. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. June, 2015.
36. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. July, 2015.
37. Gore Medical. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH, Teleconf). Training Course, Austin, TX. May, 2015.
38. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. July, 2015.
39. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. August, 2015.
40. Gore Medical. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH, Teleconf). Training Course, Austin, TX. August, 2015.
41. Silk Road Medical. Transcarotid Revascularization with Flow Reversal Carotid Stenting. (OR). Training Course, Austin, TX. August, 2015.
42. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. September, 2015.
43. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. September, 2015
44. Silk Road Medical. Transcarotid Revascularization with Flow Reversal Carotid Stenting. (OR). Training Course, Austin, TX. October, 2015.
45. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. October, 2015.
46. Medtronic. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH, Teleconf). Training Course, Austin, TX. October, 2015.
47. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. October, 2015.
48. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. November, 2015.
49. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. November, 2015.
50. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. December, 2015.
51. Medtronic. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH, Teleconf). Training Course, Austin, TX. December, 2015.Abbott. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease and Supera Stent Technology. Training Course, Austin, TX. December, 2015.
52. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. January, 2016.
53. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. January, 2016.
54. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of Peripheral Artery Disease. Training Course, Austin, TX. February , 2016.
55. Medtronic. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH, Teleconf). Training Course, Austin, TX. February , 2016.
56. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. February, 2016.
57. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomt in the Treatment of Peripheral Artery Disease Training. Course, Austin, TX. March, 2016.
58. Spectranectics. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease using Laser Atherectomy. Training Course, Austin, TX. March, 2016.
59. Abbott. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery Disease and Supera Stent Technology. Training Course, Austin, TX. April, 2016.
60. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomt in the Treatment of Peripheral Artery Disease Training. Course, Austin, TX. April, 2016.
61. Gore Medical. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH,
Teleconf). Training Course, Austin, TX. May, 2016.
62. Silk Road Medical. Transcarotid Revascularization with Flow Reversal Carotid Stenting.
(OR). Training Course, Austin, TX. June, 2016.
63. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of
Peripheral Artery Disease. Training Course, Austin, TX. July, 2016.
64. Gore Medical. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH,
Teleconf). Training Course, Austin, TX. October, 2016.
65. Abbott. (OR, CATH, Teleconf) Advancements in the Treatment of Peripheral Artery
Disease and Supera Stent Technology. Training Course, Austin, TX. November, 2016.
66. Medtronic. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH,
Teleconf). Training Course, Austin, TX. February , 2017.
67. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of
Peripherall Artery Disease. Training Course, Austin, TX. March, 2017.
68. Silkroad Medical. (OR, Teleconf) TEST Drive, Introduction to TCAR with Flow
Reversal. Training Course, Chicago, IL. May, 2017.
69. Cardiovascular Systems. (OR, CATH, Teleconf) Advancement in the Treatmet of PAD
and Wound Care. Training Course, Austin, TX. May, 2017.
70. Cardiovascular Systems. (OR, CATH, Teleconf) Orbital Atherectomy in the Treatment of
Peripherall Artery Disease. Training Course, Austin, TX. Sep, 2017.
71. Silkroad Medical. (OR, Teleconf) TEST Drive, Introduction to TCAR with Flow Reversal. Training Course, Chicago, IL. Jan, 2018.
72. Terumo. (OR, CATH, Teleconf) Percutaneous Large Bore Access and EVAR. Training
Course, Austin, TX. Feb, 2018.
73. Penumbra.(OR, CATH, Teleconf) Transcaval Coil Embolization of Endoleaks. Training
Course, Austin, TX. March, 2018.
74. Silkroad Medical. (OR, Teleconf) TEST Drive, Introduction to TCAR with Flow Reversal. Training Course, Chicago, IL. May, 2018.
75. Gore Medical. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH,
Teleconf). Training Course, Austin, TX. Sep, 2018.
76. Medtronic. Percutaneous EVAR and Complex Thoracic Aortic Repairs,(OR, CATH, Teleconf). Training Course, Austin, TX. Nov, 2018.
77. Terumo. (OR, CATH, Teleconf) Complex Lower Ext Intervention. Training
Course, Austin, TX. Jan, 2019.
78.Shockwave Medical. (OR, CATH, Teleconf) The Treatment of Complex Calcified PAD with Lithotripsy. Training Course, Austin, TX. Jan, 2019.
79. Penumbra.(OR, CATH, Teleconf) Transcaval Coil Embolization of Endoleaks. Training
Course, Austin, TX. Feb, 2019.
80. Silkroad Medical. (OR, Teleconf) TEST Drive, Introduction to TCAR with Flow Reversal.
Training Course, Chicago, IL. Mar, 2019.
81. Cardiovascular Systems. (OR, CATH, Teleconf) Advancement in the Treatmet of PAD and Wound Care. Training Course, Austin, TX. Apr, 2019.
82. Penumbra.(OR, CATH, Teleconf) Transcaval Coil Embolization of Endoleaks. Training
Course, Austin, TX. May, 2019.
83. Terumo Aortic. Percutaneous EVAR and Complex Thoracic Aortic Repairs,(OR, CATH, Teleconf). Training Course, Austin, TX. Jun, 2019.
84. Silkroad Medical. (OR, Teleconf) TEST Drive, Introduction to TCAR with Flow Reversal.
Training Course, Chicago, IL. Jun, 2019.
85. Terumo. (OR, CATH, Teleconf) Complex Lower Ext Intervention. Training
Course, Austin, TX. Jun, 2019.
86. Medtronic. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH,
Teleconf). Training Course, Austin, TX. Jun, 2019.
87. Cardiovascular Systems. (OR, CATH, Teleconf) Advancement in the Treatmet of PAD and
Wound Care. Training Course, Austin, TX. Jul, 2019.
88.Terumo. Approaches to the Treatment of Complex Endoleaks.(OR, CATH, Teleconf). Training Course, Austin, TX. Jul, 2019.
89. Penumbra.(OR, CATH, Teleconf) Transcaval Coil Embolization of Endoleaks. Training
Course, Austin, TX. Sep, 2019.
90. Cardiovascular Systems. (OR, CATH, Teleconf) Advancement in the Treatmet of PAD and
Wound Care. Training Course, Austin, TX. Nov, 2019.
91. Shockwave Medical. (OR, CATH, Teleconf) The Treatment of Complex Calcified PAD with Lithotripsy. Training Course, Austin, TX. Dec, 2019.
92. Silkroad Medical. (OR, Teleconf) TEST Drive, Introduction to TCAR with Flow Reversal.
Training Course, Chicago, IL. Dec, 2019.
93. Gore Medical. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH,
Teleconf). Training Course, Austin, TX. Dec, 2019.
94. Terumo Aortic. Percutaneous EVAR and Complex Thoracic Aortic Repairs,(OR, CATH, Teleconf). Training Course, Austin, TX. Jan, 2020.
95. Shockwave Medical. (OR, CATH, Teleconf) The Treatment of Complex Calcified PAD with Lithotripsy. Training Course, Austin, TX. Feb, 2020.
96. Silkroad Medical. (OR, Teleconf) TEST Drive, Introduction to TCAR with Flow Reversal.
Training Course, Chicago, IL. Mar, 2020.
97. C.R. Bard. (OR, CATH, Teleconf) The Treatment of Complex PAD with Rotorex Atherectomy. Training Course, Austin, TX. Mar, 2020.
98. C.R. Bard. (OR, CATH, Teleconf) The Treatment of Complex PAD with Rotorex Atherectomy. Training Course, Austin, TX. Sep, 2020.
99. C.R. Bard. (OR, CATH, Teleconf) The Treatment of Complex PAD with Rotorex Atherectomy. Training Course, Austin, TX. Dec. 2020.
100. Shockwave Medical. (OR, CATH, Teleconf) The Treatment of Complex Calcified PAD with Lithotripsy. Training Course, Austin, TX. Dec, 2020.
102. Penumbra.(OR, CATH, Teleconf) Transcaval Coil Embolization of Endoleaks. Training
Course, Austin, TX. Mar, 2021.
94. Terumo Aortic. Percutaneous EVAR and Complex Thoracic Aortic Repairs,(OR, CATH, Teleconf). Training Course, Austin, TX. Mar, 2021.
93. Gore Medical. Percutaneous EVAR and Complex Thoracic Aortic Repairs. (OR, CATH,
Teleconf). Training Course, Austin, TX. Dec, 2019.
102. Penumbra.(OR, CATH, Teleconf) Transcaval Coil Embolization of Endoleaks. Training
Course, Austin, TX. Dec, 2021.
101. Shockwave Medical. (OR, CATH, Teleconf) The Treatment of Complex Calcified PAD with Lithotripsy. Training Course, Austin, TX. Mar, 2022
102. Penumbra.(OR, CATH, Teleconf) Transcaval Coil Embolization of Endoleaks. Training
Course, Austin, TX. Mar, 2022.
GRANTS:
SCIENTIFIC
Atrium Medical, Educational Grant: $ 3,500 January, 2014
Silk Road Medical, Educational Grant: $ 2,000 January, 2014
Cardiovascular Systems, Educational Grant $ 2,000 February, 2014
Aptus Endosystems, Educational Grant: $3,000 April, 2014
Mimedx. Educational Grant: $25,000 April, 2017
RESEARCH:
NCT03477604
Micro Medical
STAND
January 2021
Principal Investigator
Status: Enrolling
Randomized multicenter clinical trial consisting of two arms; one arm treated with PTA plus the MicroStent® System and one arm treated with PTA alone. Purpose to evaluate the safety and effectiveness of using the MicroStent® Peripheral Vascular Stent System, hereafter referred to as the MicroStent® System, for the treatment of infrapopliteal lesions in subjects with peripheral arterial disease.
NCT05007925
Shockwave Medical
PAD BTK II
January 2021
Principal Investigator
Status: Enrolling
To assess the continued safety, effectiveness, and optimal clinical use of the Shockwave Medical Peripheral IVL System for the treatment of calcified, stenotic BTK arteries. Post-market, prospective , multi-center, single-arm study.
NCT03985774
Silk Road Medical
January 2021
Principal Investigator
Status: SIV
The ENROUTE Transcarotid NPS has received CE Mark and is commercially available in the European Union. The ENROUTE Transcarotid NPS may be used in conjunction with carotid artery stent approved for revascularization in patients with carotid disease in the context of this study.This is a prospective, single-arm, multi-center clinical trial of the ENROUTE Transcarotid NPS in conjunction with all commercially approved carotid artery stents used for revascularization in patients with carotid disease.The goal of this study is to evaluate the incidence of post procedure DW-MRI lesions (relative to baseline) and debris captured in the ENROUTE Transcarotid NPS inline filter during a transcarotid stenting procedure.
NCT04246463
Terumo Aortic
TREO Registry
December 2020
Principal Investigator
Status: Actively Recruiting
Post Market registry collecting real world, post-approval safety, performance, patient reported outcomes and health economic data on patients treated with Terumo Aortic endovascular stent-grafts in standard clinical practice.
NCT03033043
Terumo Aortic
RELAY PRO-D
November 2020
Investigator
Status: Actively Recruiting
This clinical trial is a prospective, multicenter, non-blinded, non-randomized study designed to assess the RelayPro thoracic endografts in the treatment of acute, complicated type B aortic dissection. The primary endpoint will measure all-cause mortality at 30 days post-procedure.
NCT04244370
C.R. Bard
MONARCH Registry
April 2020
Principal Investigator
Status: Actively Enrolling
The primary objective of this study is to evaluate the performance and safety of the Caterpillar™ Arterial Embolization Device when used for arterial embolization in the peripheral vasculature in a real world, on-label application.
NCT03756558
Terumo Medical Corporation
CROSS-SEAL IDE
August 2019
National Principal Investigator
Status: Actively Recruiting
The Cross-Seal device is a VCD intended for use in catheterization laboratories following percutaneous cardiac or peripheral procedures that use the retrograde common femoral artery access route for large bore (8‐18F ID) interventional devices. The function of Cross-Seal is to percutaneously close the puncture in the artery wall (arteriotomy) through which the catheters were inserted for the procedure. The study is being conducted to demonstrate the safety and effectiveness of Cross-Seal in achieving hemostasis in femoral arterial access sites in subjects undergoing percutaneous transcatheter interventional procedures using a large-bore procedure sheath.
NCT03193619
C.R. Bard
ULTRASCORE
January 2019
Principal Investigator
Status: Actively Enrolling
The registry is a prospective, multi-center, single-arm, real-world study to assess the clinical use of the Bard® UltraScore™ Focused Force PTA balloon for the treatment of stenotic lesions of the superficial femoral artery (SFA), popliteal artery, and infra-popliteal arteries (posterior tibial, anterior tibial and peroneal arteries). Follow-up for all treated subjects will be performed at hospital discharge, 30 days, and 6 and 12 months post-index procedure.
NCT03635190
August 2019
Cardio Flow, Inc
Principal Investigator
Status: Actively Recruiting
To evaluate the safety and effectiveness of the Cardio Flow FreedomFlow™ Orbital Circumferential Atherectomy System for atherosclerotic plaque removal and vessel compliance modification in de novo native target lesions in the peripheral vasculature of the lower extremities.
NCT02528500
W.L. Gore and Associates
GORE TAMBE Study
March 2018
Principle Investigator
Status: Actively Recruiting
This is a prospective, non-randomized study designed to assess the feasibility of the TAMBE Device in the treatment of patients with aortic aneurysms involving the visceral branch vessels. A maximum of 10 Subjects will be treated under this Protocol. This clinical study will include up to six sites in the US. Each enrolled subject will undergo periodic follow-up evaluations involving physical exams, contrast-enhanced computed tomography (CT) of chest, abdomen and pelvis, creatinine measurement, abdominal ultrasound (optional) at specific, protocol-defined intervals for a period of five years following the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis implant.
NCT01534819
Medtronic Endovascular
February 2018
Principal Investigator
Status: Closed
Placement of the Aptus Heli-FX™ EndoAnchor System in subjects for the prevention of graft migration and the treatment of Type Ia endoleak or Aptus Heli-FX EndoAnchor System placed at the time of initial endograft implantation, either to prevent endograft migration and Type Ia endoleak, or to treat Type Ia endoleak evident at the time of implantation.
NCT02777593
W.L. Gore and Associates
GORE TAG TBE Study
February 2017
Co-Investigator
Status: Recruitment Pause
The objective of this study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta
NCT0253637
Silk Road Medical
ROADSTER 2 Registry
Principal Investigator
November 2015
Principle Investigator
Status: Closed
The ROADSTER 2 Registry is intended to evaluate real world usage of the ENROUTE Transcarotid Stent when used with the ENROUTE Transcarotid Neuroprotection System by physicians of varying experience transcarotid technique.
NCT02414841
July 2015
Co-Investigator
Status: Closed
This research study is designed to assess the safety and effectiveness of an experimental drug called vonapanitase (PRT-201) in patients who have chronic kidney disease and who are undergoing surgery to create a new access point to their bloodstream for hemodialysis.
NCT02393716
Medtronic Medical
ENDURANT EVO
June 2015
Co-Investigator
Status: Closed
The purpose of this study is to demonstrate that the Endurant Evo AAA stent graft system is safe and effective for endovascular treatment of infrarenal abdominal aortic or aortoiliac aneurysms
NCT02089217
National Institutes of Health
CREST 2 Study
February 2015
Principal Investigator
Status: Closed
Carotid revascularization for primary prevention of stroke (CREST-2) in two multicenter, randomized controlled trials of carotid revascularization and intensive medical management versus medical management alone in patients with asymptomatic high-grade carotid stenosis. One trial will randomize patients in a 1:1 ratio to endarterectomy versus no endarterectomy and another will randomize patients in a 1:1 ratio to carotid stenting with embolic protection versus no stenting.
NCT02240862
National Institutes of Health
The CREST-2 Companion Registry (C2R)
February 2015
Principal Investigator
Status: Closed
The objective of the CREST-2 Registry is to promote the rapid initiation and completion of enrollment in the CREST-2 randomized clinical trial (clinicaltrials.gov ID NCT02089217). results from the CREST-2 randomized clinical trial.
NCT01855412
Cardiovascular Systems
Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes LIBERTY
April 2015
Principal Investigator
Status: Closed
The purpose of this study is to evaluate acute and long-term clinical and economic outcomes of endovascular procedures to treat Peripheral Arterial Disease (PAD).
NCT01658787
W.L. Gore and Associates GREAT Outcomes Evaluation June 2014
Co-Investigator
Status: Closed
This is a prospective observational cohort Registry designed to obtain data on device performance and clinical outcomes of patients treated with Gore endovascular aortic products.
NCT01904851
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes XLPAD
The University of Texas Southwestern July 2014
Principal Investigator
Status: Actively Recruiting
XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that will include entry of procedural and clinical follow-up information into an online data collection software, REDCAP.
Outcomes Study for Thoracic Aortic Dissection Treatment with Thoracic Endograft Society of Vascular Surgeons
August 2014
Principal Investigator
Status: Closed
The purpose of this study is to evaluate outcomes of thoracic endografts in the treatment of sub-acute and chronic Type B thoracic aortic dissection
NCT01685567
Silk Road Medical
Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure
ROADSTER
June 2013
Principal Investigator
Status: Closed
The purpose of this study is to evaluate the safety and effectiveness of the MICHI™ Neuroprotection System with Filter (MICHI™ NPS+f) in providing cerebral embolic protection during carotid artery stenting. It will be used in conjunction with a FDA approved carotid artery stent for the treatment of carotid artery disease.
NCT01970007
Cook Medical
VIVO Clinical Study
June 2013
Co-Investigator
Status: Closed
The purpose of the VIVO Clinical Study is to evaluate the safety and effectiveness of the Zilver® Vena™ Venous Stent in the treatment of symptomatic iliofemoral venous outflow obstruction.